These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3527706)

  • 1. Amitriptyline and oxaprotiline in the treatment of hospitalized depressive patients. Clinical aspects, psychophysiology, and drug plasma levels.
    Giedke H; Gaertner H; Breyer-Pfaff U; Rein W; Axmann D
    Eur Arch Psychiatry Neurol Sci; 1986; 235(6):329-38. PubMed ID: 3527706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in slow evoked potentials in depressed patients treated with amitriptyline and oxaprotiline].
    Giedke H; Heimann H; Rein W
    Rev Electroencephalogr Neurophysiol Clin; 1987 Sep; 17(3):279-87. PubMed ID: 3685573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biochemical, pharmacologic and psychophysiologic studies for the optimization of drug therapy in depressive illnesses].
    Gaertner HJ; Giedke H; Breyer-Pfaff U
    Nervenarzt; 1984 Mar; 55(3):133-6. PubMed ID: 6717696
    [No Abstract]   [Full Text] [Related]  

  • 4. Double-blind study of oxaprotiline versus clomipramine in the treatment of depressive inpatients.
    Wolfersdorf M; Binz U; Wendt G; Metzger R; Hole G
    Neuropsychobiology; 1987; 17(1-2):41-8. PubMed ID: 3306439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxaprotiline in the treatment of endogenous depressed inpatients an early clinical trial.
    Schmauss M; Laakmann G; Dieterle D; Blaschke D
    Pharmacopsychiatry; 1985 Jul; 18(4):282-5. PubMed ID: 3895255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to maprotiline treatment in depressive patients relationship to urinary MHPG excretion and plasma drug level.
    Gaertner HJ; Golfinopoulos G; Breyer-Pfaff U
    Pharmacopsychiatria; 1982 Sep; 15(5):170-4. PubMed ID: 7178231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of levoprotiline and amitriptyline in endogenous depressions.
    Faltus F; Molcan J; Svestka J; Náhunek K; Mrna B; Zapletálek M; Krekule P; Janecková E; Koníková M; Pazdírek S
    Act Nerv Super (Praha); 1989 Dec; 31(4):279-80. PubMed ID: 2638109
    [No Abstract]   [Full Text] [Related]  

  • 8. A clinical test of noradrenergic involvement in the therapeutic mode of action of an experimental antidepressant.
    Katz RJ; Lott M; Landau P; Waldmeier P
    Biol Psychiatry; 1993 Feb; 33(4):261-6. PubMed ID: 8471679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amitriptyline and nortriptyline plasma levels, urinary 3-methoxy-4-hydroxyphenylglycol and clinical response in depressed women.
    Corona GL; Cucchi ML; Frattini P; Santagostino G; Schinelli S; Comincioli V; Zerbi F; Fenoglio L; Savoldi F
    Neuropsychobiology; 1986; 16(2-3):97-102. PubMed ID: 3587582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CGP 12.103 A versus clomipramine in the treatment of depressed inpatients--results of a double-blind study.
    Wolfersdorf M; Wendt G; Binz U; Steiner B; Hole G
    Pharmacopsychiatry; 1988 Jul; 21(4):203-7. PubMed ID: 3060885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and efficacy of maprotiline and amitriptyline in endogenous depression: a double-blind controlled trial.
    Montgomery SA; McAuley R; Montgomery DB; Dawling S; Braithwaite RA
    Clin Ther; 1980; 3(4):292-310. PubMed ID: 7023677
    [No Abstract]   [Full Text] [Related]  

  • 12. Long term treatment with oxaprotiline in patients with major depression.
    Katz RJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(6):875-83. PubMed ID: 2813805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels, psychophysiological variables, and clinical response to amitriptyline.
    Breyer-Pfaff U; Gaertner HJ; Giedke H
    Psychiatry Res; 1982 Apr; 6(2):223-34. PubMed ID: 6953461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The Eppendorf Mood and Motivation Scale as assessment procedure in the clinical evaluation of an antidepressive agent].
    Binz U; Wendt G
    Fortschr Med; 1982 Dec; 100(45):2111-7. PubMed ID: 6757074
    [No Abstract]   [Full Text] [Related]  

  • 15. Serotonin reuptake inhibition vs. norepinephrine reuptake inhibition: a double-blind differential-therapeutic study with fluvoxamine and oxaprotiline in endogenous and neurotic depressives.
    Emrich HM; Berger M; Riemann D; von Zerssen D
    Pharmacopsychiatry; 1987 Mar; 20(2):60-3. PubMed ID: 3108909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-bind comparison of maprotiline with amitriptyline in the treatment of depressive illness.
    Trick KL
    Int Pharmacopsychiatry; 1975; 10(4):193-8. PubMed ID: 765292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind trial of maprotiline (Ludiomil) and amitriptyline in depressed outpatients.
    Weissman MM; Lieb J; Prusoff B; Bothwell S
    Acta Psychiatr Scand; 1975 Oct; 52(4):225-36. PubMed ID: 1103574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressive effect and pharmacokinetics of amitriptyline with consideration of unbound drug and 10-hydroxynortriptyline plasma levels.
    Breyer-Pfaff U; Gaertner HJ; Kreuter F; Scharek G; Brinkschulte M; Wiatr R
    Psychopharmacology (Berl); 1982; 76(3):240-4. PubMed ID: 6808544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mianserin and maprotiline as compared to amitriptyline in severe endogenous depression. A new methodological approach to the clinical evaluation of the efficacy of antidepressants.
    Cording-Tömmel C; von Zerssen D
    Pharmacopsychiatria; 1982 Nov; 15(6):197-204. PubMed ID: 7156183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative speed of onset of the antidepressant effect of maprotiline.
    Silverstone T
    Clin Ther; 1981; 3(5):374-81. PubMed ID: 7471133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.